Vonoprazan Fumarate is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB). It inhibits gastric acid secretion by competitively binding to the potassium ion binding site of the gastric H+/K+ ATPase proton pump.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2098974-13-9
Vonoprazan
active pharmaceutical ingredient
Vonoprazan Fumarate
active pharmaceutical ingredient
Vonoprazan Fumarate
potassium-competitive acid blocker
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanol
Pharmaceutical intermediate
5-(2-Fluorophenyl)-N,N-dimethyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine
n.a
Tegoprazan
potassium-competitive acid blocker
Revaprazan Hydrochloride
potassium-competitive acid blocker
Abeprazan
potassium-competitive acid blocker
(E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine
ROGSHYHKHPCCJW-WLHGVMLRSA-N
CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=C/C(=O)O)\C(=O)O